Formula: | C18H17ClF2N4O3 |
Molecular Weight: | 410.81 |
Rotatable Bond Donors: | 3 |
clogP: | 3.41 |
Topological Polar Surface Area: | 66.93 |
Lipinski's RO5: | MW: 410.81 HBA: 7 HBD: 1 RB: 3 LogP: 3.41 |
Rule of Three: | MW: 410.81 HBA: 7 HBD: 1 RB: 3 LogP: 3.41 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC168658420 | 1.0 | ZINC168658420 RDKit 3D 28 31 0 0 0 0 0 0 0 0999 V2000 -3.8040 1.2830 1.9880 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3680 0.6481 1.0302 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.1101 0.2844 -0.0792 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.4622 0.5774 -0.3080 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.2373 1.2945 0.5902 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.5435 1.5935 0.3994 N 0 0 0 0 0 0 0 0 0 0 0 0 -8.1056 1.1556 -0.7461 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.4281 0.4333 -1.7102 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0880 0.1462 -1.4765 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.2479 -0.7572 -2.6850 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -2.0550 0.2121 0.9828 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.1428 0.7218 1.9873 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0857 -0.1682 2.1597 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7463 -0.4756 0.8901 N 0 0 0 0 0 0 0 0 0 0 0 0 1.8014 -1.4305 1.1902 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0154 -1.2111 0.3488 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1714 -1.9287 -0.8508 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2980 -1.7485 -1.6539 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2468 -0.8468 -1.2195 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1018 -0.1478 -0.0420 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9976 -0.3088 0.7683 C 0 0 0 0 0 0 0 0 0 0 0 0 6.1505 0.6831 0.2029 O 0 0 0 0 0 0 0 0 0 0 0 0 6.9533 0.4216 -0.9559 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1402 1.5863 -1.6234 F 0 0 0 0 0 0 0 0 0 0 0 0 8.1689 -0.0170 -0.5466 F 0 0 0 0 0 0 0 0 0 0 0 0 6.4050 -0.5423 -1.8654 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.2277 -1.1569 0.0359 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4622 -0.3018 -0.2403 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 2 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 2 0 9 10 1 0 2 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 15 16 1 0 16 17 2 0 17 18 1 0 18 19 2 0 19 20 1 0 20 21 2 0 20 22 1 0 22 23 1 0 23 24 1 0 23 25 1 0 23 26 1 0 14 27 1 0 27 28 1 0 9 4 1 0 28 11 1 0 21 16 1 0 26 19 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |